Company Filing History:
2 out of 136 
1 out of 70 
1 out of 113 
Years Active: 2020-2024
Title: Rie Kinoshita: Innovator in Cancer Research
Introduction
Rie Kinoshita is a prominent inventor based in Okayama, Japan. She has made significant contributions to the field of cancer research, particularly through her innovative patents. With a total of 2 patents, Kinoshita's work focuses on developing antibodies that target specific proteins associated with cancer.
Latest Patents
Kinoshita's latest patents include the "Anti-S100A8/A9 antibody and use thereof." This invention provides a substance capable of effectively suppressing cancer metastasis or a pharmaceutical composition that acts on inflammatory diseases. The composition contains an antibody or an antibody fragment that binds to the S100A8/A9 heterodimer, blocking its interaction with receptors and thereby suppressing cancer metastasis both in vitro and in vivo, or alleviating inflammation.
Another notable patent is the "Anti-REIC/Dkk-3 antibody," which specifically recognizes the REIC/Dkk-3 protein associated with cancer. This invention enables monitoring of cancer treatment effects and provides a method for cancer detection by measuring the REIC/Dkk-3 protein concentration in biological samples. This method can help determine if a subject is suffering from precancer or a neoplastic disease.
Career Highlights
Kinoshita has worked with reputable institutions such as Okayama University and Niigata University. Her research has significantly advanced the understanding of cancer treatment and diagnosis.
Collaborations
Some of her notable coworkers include Junichiro Futami and Masakiyo Sakaguchi. Their collaborative efforts have contributed to the success of her research projects.
Conclusion
Rie Kinoshita's innovative work in cancer research through her patents demonstrates her commitment to advancing medical science. Her contributions have the potential to improve cancer treatment and diagnosis, making her a valuable figure in the field.